We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.78B
AUM Growth
-$2.15B
Cap. Flow
-$2.29B
Cap. Flow %
-60.64%
Top 10 Hldgs %
32.15%
Holding
6,174
New
508
Increased
1,418
Reduced
3,468
Closed
480

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$269M
2
SMCI icon
Super Micro Computer
SMCI
+$220M
3
SPXL icon
Direxion Daily S&P 500 Bull 3x ETF
SPXL
+$68M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$61M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$33.5M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$215M
2
MSFT icon
Microsoft
MSFT
+$203M
3
NVDA icon
NVIDIA
NVDA
+$156M
4
AMZN icon
Amazon
AMZN
+$119M
5
META icon
Meta Platforms (Facebook)
META
+$97.9M

Sector Composition

Rank Sector Weight
1 Technology 21.67%
2 Financials 9.06%
3 Consumer Discretionary 7.38%
4 Healthcare 7.08%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAMS icon
2026
NewAmsterdam Pharma
NAMS
$3.3B
$129K ﹤0.01%
+7,782
New +$135K
TDSC icon
2027
Exchange Listed Funds Trust ETC Cabana Target Drawdown 10 ETF
TDSC
$106M
$129K ﹤0.01%
5,071
-6
-0.1% -$148
TU icon
2028
Telus
TU
$15.2B
$129K ﹤0.01%
7,670
+3,460
+82% +$55.9K
PKST
2029
DELISTED
Peakstone Realty Trust
PKST
$129K ﹤0.01%
9,438
+2,695
+40% +$35.3K
WEN icon
2030
Wendy's
WEN
$1.44B
$129K ﹤0.01%
7,341
-43,663
-86% -$743K
RCKT icon
2031
Rocket Pharmaceuticals
RCKT
$382M
$129K ﹤0.01%
6,958
-7,647
-52% -$157K
RWAY icon
2032
Runway Growth Finance
RWAY
$281M
$128K ﹤0.01%
12,478
+11,403
+1,061% +$125K
ZM icon
2033
Zoom
ZM
$31.1B
$128K ﹤0.01%
1,835
-4,900
-73% -$306K
LIVN icon
2034
LivaNova
LIVN
$4.33B
$128K ﹤0.01%
2,433
-7,937
-77% -$393K
QDEL icon
2035
QuidelOrtho
QDEL
$959M
$128K ﹤0.01%
2,797
-78,020
-97% -$3.16M
BZH icon
2036
Beazer Homes USA
BZH
$874M
$127K ﹤0.01%
3,728
-897
-19% -$27.6K
LIF
2037
Life360
LIF
$3.94B
$127K ﹤0.01%
+3,235
New +$113K
AMTB icon
2038
Amerant Bancorp
AMTB
$1.14B
$127K ﹤0.01%
5,955
-125
-2% -$2.75K
VERV
2039
DELISTED
Verve Therapeutics
VERV
$127K ﹤0.01%
26,287
+1,525
+6% +$8.86K
PLAY icon
2040
Dave & Buster's
PLAY
$349M
$127K ﹤0.01%
3,736
-13,803
-79% -$471K
BHC icon
2041
Bausch Health
BHC
$2.33B
$127K ﹤0.01%
15,583
+12,620
+426% +$83.2K
MRVI icon
2042
Maravai LifeSciences
MRVI
$866M
$127K ﹤0.01%
15,298
+9,955
+186% +$86.1K
MT icon
2043
ArcelorMittal
MT
$55.6B
$127K ﹤0.01%
4,841
-1,114
-19% -$25.5K
OPCH icon
2044
Option Care Health
OPCH
$3.61B
$127K ﹤0.01%
4,060
-48,754
-92% -$1.5M
SFL icon
2045
SFL Corp
SFL
$1.54B
$127K ﹤0.01%
10,976
-13,352
-55% -$160K
SXT icon
2046
Sensient Technologies
SXT
$5.61B
$127K ﹤0.01%
1,581
-3,781
-71% -$287K
CALY
2047
Callaway Golf Company
CALY
$3.01B
$127K ﹤0.01%
11,543
-11,507
-50% -$145K
FL
2048
DELISTED
Foot Locker
FL
$127K ﹤0.01%
4,901
-13,822
-74% -$382K
BBBY
2049
Bed Bath & Beyond
BBBY
$407M
$127K ﹤0.01%
13,819
+3,767
+37% +$38.8K
MC icon
2050
Moelis & Co
MC
$4.93B
$126K ﹤0.01%
1,845
-11,909
-87% -$769K
80 81
82
83 84

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2024 Portfolio in Review

As of Q3 2024, Tower Research Capital (TRC) held 6,174 positions worth $3.78B, down 36% from $5.92B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.29B in Q3 2024, closing 480 positions and reducing 3,468 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $9.26M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares US Technology ETF worth $6.83M.

  • Tower Research Capital (TRC)'s largest Q3 2024 buy was iShares US Technology ETF: 45,025 shares worth $6.83M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q3 2024, an estimated $269M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2024 reduction was Apple, cutting an estimated $215M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2024, selling an estimated $9.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.78B portfolio in Q3 2024.
  • Tower Research Capital (TRC) opened 508 new positions and closed 480 in Q3 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $3.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.